| (R)-noradrenaline | increases expression | ISO | RGD:3932 | 6480464 | Norepinephrine results in increased expression of UCP2 mRNA | CTD | PMID:12588052 PMID:8593794 |
| (R)-noradrenaline | increases expression | ISO | RGD:3932 | 6480464 | Norepinephrine results in increased expression of UCP2 mRNA | CTD | PMID:8593794 PMID:12588052 |
| 17alpha-ethynylestradiol | affects expression | EXP | | 6480464 | Ethinyl Estradiol affects the expression of UCP2 mRNA | CTD | PMID:17555576 |
| 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UCP2 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of UCP2 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:69170 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of UCP2 mRNA | CTD | PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:69170 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of UCP2 mRNA | CTD | PMID:20106945 PMID:21632981 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of UCP2 mRNA | CTD | PMID:15328365 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of UCP2 mRNA | CTD | PMID:18163543 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of UCP2 mRNA | CTD | PMID:18796159 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of UCP2 mRNA | CTD | PMID:18163543 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of UCP2 mRNA | CTD | PMID:20399798 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of UCP2 mRNA | CTD | PMID:19933214 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of UCP2 mRNA | CTD | PMID:15328365 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UCP2 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of UCP2 mRNA | CTD | PMID:16214954 |
| 2-amino-2-deoxy-D-glucopyranose | decreases expression | ISO | RGD:3932 | 6480464 | Glucosamine results in decreased expression of UCP2 mRNA | CTD | PMID:11893929 |
| 2-methylcholine | affects expression | ISO | RGD:69170 | 6480464 | beta-methylcholine affects the expression of UCP2 mRNA | CTD | PMID:21179406 |
| 3,3',5-triiodo-L-thyronine | multiple interactions | ISO | RGD:3932 | 6480464 | THRB protein alternative form affects the reaction [Triiodothyronine promotes the reaction [Thiazolidinediones results in increased expression of UCP2]]; more ... | CTD | PMID:12588052 |
| aldehydo-D-glucosamine | decreases expression | ISO | RGD:3932 | 6480464 | Glucosamine results in decreased expression of UCP2 mRNA | CTD | PMID:11893929 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of UCP2 mRNA | CTD | PMID:16840543 |
| alpha-linolenic acid | increases expression | ISO | RGD:3932 | 6480464 | alpha-Linolenic Acid results in increased expression of UCP2 mRNA | CTD | PMID:11341955 |
| ammonium chloride | affects expression | ISO | RGD:3932 | 6480464 | Ammonium Chloride affects the expression of UCP2 mRNA | CTD | PMID:16483693 |
| antimycin A | increases expression | EXP | | 6480464 | Antimycin A results in increased expression of UCP2 protein | CTD | PMID:18082129 |
| ATP | multiple interactions | ISO | RGD:69170 | 6480464 | Adenosine Triphosphate inhibits the reaction [UCP2 protein results in increased transport of Protons] | CTD | PMID:12734183 |
| ATP | multiple interactions | ISO | RGD:3932 | 6480464 | [SIRT1 protein results in decreased expression of UCP2 mRNA] promotes the reaction [Glucose results in increased abundance of Adenosine Triphosphate] | CTD | PMID:16366736 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | Benzo(a)pyrene inhibits the reaction [Dietary Fats results in increased expression of UCP2 mRNA]; more ... | CTD | PMID:20412841 |
| benzo[a]pyrene | increases expression | ISO | RGD:69170 | 6480464 | Benzo(a)pyrene results in increased expression of UCP2 mRNA | CTD | PMID:20106945 PMID:21632981 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of UCP2 mRNA | CTD | PMID:21569818 |
| benzo[a]pyrene | increases expression | ISO | RGD:69170 | 6480464 | Benzo(a)pyrene results in increased expression of UCP2 mRNA | CTD | PMID:20106945 |
| beta-D-glucosamine | decreases expression | ISO | RGD:3932 | 6480464 | Glucosamine results in decreased expression of UCP2 mRNA | CTD | PMID:11893929 |
| bezafibrate | increases expression | EXP | | 6480464 | Bezafibrate results in increased expression of UCP2 mRNA | CTD | PMID:11056218 |
| bezafibrate | increases expression | ISO | RGD:3932 | 6480464 | Bezafibrate results in increased expression of UCP2 mRNA | CTD | PMID:11473052 PMID:12588052 |
| bezafibrate | multiple interactions | ISO | RGD:3932 | 6480464 | Triiodothyronine promotes the reaction [Bezafibrate results in increased expression of UCP2 mRNA] | CTD | PMID:12588052 |
| bezafibrate | multiple interactions | ISO | RGD:3932 | 6480464 | [Bezafibrate binds to and results in increased activity of PPARA protein] which results in increased expression of UCP2 mRNA | CTD | PMID:11341955 |
| bezafibrate | increases expression | ISO | RGD:3932 | 6480464 | Bezafibrate results in increased expression of UCP2 mRNA | CTD | PMID:12588052 PMID:11473052 |
| bezafibrate | affects expression | ISO | RGD:3932 | 6480464 | Bezafibrate affects the expression of UCP2 mRNA | CTD | PMID:10933891 |
| bis(2-ethylhexyl) phthalate | decreases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in decreased expression of UCP2 mRNA | CTD | PMID:19245819 |
| bisphenol A | increases expression | ISO | RGD:3932 | 6480464 | bisphenol A results in increased expression of UCP2 mRNA | CTD | PMID:22946080 |
| candesartan | decreases expression | ISO | RGD:3932 | 6480464 | candesartan results in decreased expression of UCP2 mRNA | CTD | PMID:16685210 |
| candesartan | multiple interactions | EXP | | 6480464 | candesartan inhibits the reaction [Palmitic Acid results in increased expression of UCP2 mRNA] | CTD | PMID:20667613 |
| capsaicin | affects response to substance | ISO | RGD:69170 | 6480464 | UCP2 protein polymorphism affects the susceptibility to Capsaicin analog | CTD | PMID:19056576 |
| capsaicin | multiple interactions | ISO | RGD:3932 | 6480464 | Capsaicin inhibits the reaction [Dietary Fats results in decreased expression of UCP2 mRNA] | CTD | PMID:20359164 |
| carbon monoxide | multiple interactions | EXP | | 6480464 | UCP2 protein promotes the reaction [Carbon Monoxide inhibits the reaction [Lipopolysaccharides results in increased expression of EGR1 protein]]; more ... | CTD | PMID:22046279 |
| choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of UCP2 mRNA | CTD | PMID:20938992 |
| ciglitazone | decreases expression | EXP | | 6480464 | ciglitazone results in decreased expression of UCP2 mRNA | CTD | PMID:11056218 |
| cisplatin | affects response to substance | ISO | RGD:69170 | 6480464 | UCP2 protein affects the susceptibility to Cisplatin | CTD | PMID:16217747 |
| cobalt dichloride | decreases expression | ISO | RGD:69170 | 6480464 | cobaltous chloride results in decreased expression of UCP2 mRNA | CTD | PMID:12032628 PMID:19376846 |
| copper(2+) sulfate | decreases expression | ISO | RGD:69170 | 6480464 | Copper Sulfate results in decreased expression of UCP2 mRNA | CTD | PMID:19549813 |
| cycloheximide | multiple interactions | ISO | RGD:3932 | 6480464 | Cycloheximide inhibits the reaction [Thiazolidinediones results in increased expression of UCP2 mRNA] | CTD | PMID:12588051 |
| D-glucose | multiple interactions | ISO | RGD:3932 | 6480464 | [SIRT1 protein results in decreased expression of UCP2 mRNA] promotes the reaction [Glucose results in increased abundance of Adenosine Triphosphate]; more ... | CTD | PMID:16366736 |
| D-glucose | increases expression | ISO | RGD:69170 | 6480464 | Glucose results in increased expression of UCP2 protein | CTD | PMID:18167556 |
| desferrioxamine B | decreases expression | ISO | RGD:69170 | 6480464 | Deferoxamine results in decreased expression of UCP2 mRNA | CTD | PMID:12032628 |
| dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of UCP2 mRNA | CTD | PMID:17998272 |
| dexamethasone | increases expression | ISO | RGD:69170 | 6480464 | Dexamethasone results in increased expression of UCP2 mRNA | CTD | PMID:19853017 |
| diarsenic trioxide | increases expression | ISO | RGD:69170 | 6480464 | arsenic trioxide results in increased expression of UCP2 mRNA | CTD | PMID:15761015 |
| diazoxide | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of UCP2 mRNA | CTD | PMID:20003209 |
| diazoxide | multiple interactions | ISO | RGD:3932 | 6480464 | phenylmethylpyrazolone inhibits the reaction [Isoproterenol results in increased expression of UCP2 mRNA]; more ... | CTD | PMID:16580698 |
| diazoxide | increases expression | ISO | RGD:3932 | 6480464 | Isoproterenol results in increased expression of UCP2 mRNA; more ... | CTD | PMID:16580698 |
| dioxygen | decreases expression | ISO | RGD:69170 | 6480464 | Oxygen deficiency results in decreased expression of UCP2 mRNA | CTD | PMID:12032628 |
| dioxygen | multiple interactions | EXP | | 6480464 | Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of UCP2 mRNA] | CTD | PMID:22629407 |
| dioxygen | increases expression | EXP | | 6480464 | Oxygen deficiency results in increased expression of UCP2 mRNA | CTD | PMID:22629407 |
| dioxygen | decreases expression | EXP | | 6480464 | Oxygen deficiency results in decreased expression of UCP2 mRNA | CTD | PMID:21113404 |
| dioxygen | multiple interactions | EXP | | 6480464 | [4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid co-treated with Oxygen deficiency] results in increased expression of UCP2 protein; more ... | CTD | PMID:21113404 |
| disodium selenite | multiple interactions | EXP | | 6480464 | Sodium Selenite inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of UCP2 mRNA] | CTD | PMID:15650415 |
| disodium selenite | decreases expression | EXP | | 6480464 | Sodium Selenite results in decreased expression of UCP2 mRNA; more ... | CTD | PMID:15650415 |
| doxorubicin | decreases expression | ISO | RGD:3932 | 6480464 | Doxorubicin results in decreased expression of UCP2 mRNA | CTD | PMID:19915844 |
| edaravone | multiple interactions | ISO | RGD:3932 | 6480464 | phenylmethylpyrazolone inhibits the reaction [Isoproterenol results in increased expression of UCP2 mRNA]; more ... | CTD | PMID:16580698 |
| ethanol | decreases expression | EXP | | 6480464 | Ethanol results in decreased expression of UCP2 mRNA | CTD | PMID:20007851 |
| ethanol | multiple interactions | EXP | | 6480464 | rosiglitazone inhibits the reaction [Ethanol results in decreased expression of UCP2 mRNA] | CTD | PMID:20007851 |
| fenofibrate | multiple interactions | ISO | RGD:3932 | 6480464 | [Fenofibrate binds to and results in increased activity of PPARA protein] which results in increased expression of UCP2 mRNA | CTD | PMID:11341955 |
| folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of UCP2 mRNA | CTD | PMID:20938992 |
| furan | increases expression | ISO | RGD:3932 | 6480464 | furan results in increased expression of UCP2 mRNA | CTD | PMID:15120968 |
| gadolinium trichloride | multiple interactions | ISO | RGD:3932 | 6480464 | gadolinium chloride inhibits the reaction [Carbon Tetrachloride results in increased expression of UCP2 mRNA] | CTD | PMID:18314881 |
| glucose | multiple interactions | ISO | RGD:3932 | 6480464 | [SIRT1 protein results in decreased expression of UCP2 mRNA] promotes the reaction [Glucose results in increased abundance of Adenosine Triphosphate]; more ... | CTD | PMID:16366736 |
| glucose | increases expression | ISO | RGD:69170 | 6480464 | Glucose results in increased expression of UCP2 protein | CTD | PMID:18167556 |
| glutathione | multiple interactions | ISO | RGD:3932 | 6480464 | Glutathione inhibits the reaction [[pirinixic acid results in increased expression of UCP2 protein] which results in increased abundance of Hydrogen Peroxide] | CTD | PMID:19361538 |
| histamine | decreases secretion | ISO | RGD:69170 | 6480464 | UCP2 protein results in decreased secretion of Histamine | CTD | PMID:19846869 |
| histamine | affects secretion | EXP | | 6480464 | UCP2 protein affects the secretion of Histamine | CTD | PMID:19846869 |
| histamine | affects abundance | EXP | | 6480464 | UCP2 protein affects the abundance of Histamine | CTD | PMID:19846869 |
| hydrogen peroxide | multiple interactions | ISO | RGD:3932 | 6480464 | [pirinixic acid results in increased expression of UCP2 protein] which results in increased abundance of Hydrogen Peroxide; more ... | CTD | PMID:19361538 |
| hydrogen peroxide | multiple interactions | ISO | RGD:3932 | 6480464 | [[benzo(a)pyrene-1,6-quinone results in increased abundance of Superoxides] co-treated with [benzo(a)pyrene-1,6-quinone results in decreased abundance of Hydrogen Peroxide]] results in increased expression of UCP2 mRNA | CTD | PMID:10860543 |
| indomethacin | increases expression | ISO | RGD:69170 | 6480464 | Indomethacin results in increased expression of UCP2 mRNA | CTD | PMID:16984733 |
| isoprenaline | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of UCP2 mRNA | CTD | PMID:20003209 |
| isoprenaline | multiple interactions | ISO | RGD:3932 | 6480464 | phenylmethylpyrazolone inhibits the reaction [Isoproterenol results in increased expression of UCP2 mRNA]; more ... | CTD | PMID:16580698 |
| isoprenaline | increases expression | ISO | RGD:3932 | 6480464 | Isoproterenol results in increased expression of UCP2 protein; more ... | CTD | PMID:16580698 |
| L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of UCP2 mRNA | CTD | PMID:20938992 |
| lactacystin | multiple interactions | ISO | RGD:3932 | 6480464 | lactacystin inhibits the reaction [[pirinixic acid results in increased expression of UCP2 protein] which results in increased degradation of BCL2 protein] | CTD | PMID:19361538 |
| losartan | decreases expression | EXP | | 6480464 | Losartan results in decreased expression of UCP2 mRNA; more ... | CTD | PMID:17508912 |
| losartan | multiple interactions | ISO | RGD:3932 | 6480464 | Losartan inhibits the reaction [AGT protein results in increased expression of UCP2 mRNA] | CTD | PMID:19109942 |
| menadione | affects expression | ISO | RGD:69170 | 6480464 | Vitamin K 3 affects the expression of UCP2 mRNA | CTD | PMID:20044591 |
| myxothiazol | increases expression | EXP | | 6480464 | myxothiazol results in increased expression of UCP2 protein | CTD | PMID:18082129 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:3932 | 6480464 | Acetylcysteine inhibits the reaction [pirinixic acid results in increased expression of UCP2 protein] | CTD | PMID:18183618 |
| N-methyl-N'-nitro-N-nitrosoguanidine | multiple interactions | EXP | | 6480464 | [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of UCP2 mRNA | CTD | PMID:19840844 |
| nicotinamide | multiple interactions | EXP | | 6480464 | Niacinamide inhibits the reaction [[SIRT1 protein binds to UCP2 promoter] which results in decreased expression of UCP2 mRNA] | CTD | PMID:16366736 |
| nicotinamide | multiple interactions | EXP | | 6480464 | Niacinamide inhibits the reaction [[SIRT1 protein binds to UCP2 promoter] which results in decreased expression of UCP2 mRNA] | CTD | PMID:16366736 PMID:16366736 |
| ochratoxin A | decreases expression | ISO | RGD:3932 | 6480464 | ochratoxin A results in decreased expression of UCP2 mRNA | CTD | PMID:22124623 |
| ochratoxin A | increases expression | ISO | RGD:69170 | 6480464 | ochratoxin A results in increased expression of UCP2 mRNA | CTD | PMID:17316727 |
| ochratoxin A | decreases expression | ISO | RGD:69170 | 6480464 | ochratoxin A results in decreased expression of UCP2 mRNA | CTD | PMID:22124623 PMID:19287073 |
| ochratoxin A | decreases expression | ISO | RGD:69170 | 6480464 | ochratoxin A results in decreased expression of UCP2 mRNA | CTD | PMID:19287073 PMID:22124623 |
| okadaic acid | multiple interactions | EXP | | 6480464 | [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of UCP2 mRNA | CTD | PMID:19840844 |
| oleic acid | increases expression | ISO | RGD:3932 | 6480464 | Oleic Acid results in increased expression of UCP2 mRNA | CTD | PMID:11341955 PMID:12588052 |
| oleic acid | increases expression | ISO | RGD:3932 | 6480464 | Oleic Acid results in increased expression of UCP2 mRNA | CTD | PMID:12588052 PMID:11341955 |
| palmitic acid | increases activity | ISO | RGD:69170 | 6480464 | Palmitic Acid results in increased activity of UCP2 protein | CTD | PMID:12858170 |
| palmitic acid | increases expression | EXP | | 6480464 | Palmitic Acid results in increased expression of UCP2 mRNA | CTD | PMID:20667613 |
| palmitic acid | multiple interactions | EXP | | 6480464 | candesartan inhibits the reaction [Palmitic Acid results in increased expression of UCP2 mRNA] | CTD | PMID:20667613 |
| paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of UCP2 mRNA | CTD | PMID:17562736 |
| paraquat | decreases response to substance | ISO | RGD:69170 | 6480464 | UCP2 protein results in decreased susceptibility to Paraquat | CTD | PMID:16054055 |
| perfluorooctanoic acid | increases expression | ISO | RGD:3932 | 6480464 | perfluorooctanoic acid results in increased expression of UCP2 mRNA | CTD | PMID:19162173 |
| perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of UCP2 mRNA | CTD | PMID:21499893 |
| pirinixic acid | multiple interactions | EXP | | 6480464 | etomoxir promotes the reaction [pirinixic acid results in increased expression of UCP2 protein]; more ... | CTD | PMID:16306367 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of UCP2 mRNA | CTD | PMID:11056218 more ... |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of UCP2 mRNA | CTD | PMID:20813756 more ... |
| pirinixic acid | increases expression | ISO | RGD:3932 | 6480464 | pirinixic acid results in increased expression of UCP2 protein | CTD | PMID:18183618 more ... |
| pirinixic acid | increases expression | ISO | RGD:3932 | 6480464 | pirinixic acid results in increased expression of UCP2 protein | CTD | PMID:16782780 more ... |
| pirinixic acid | increases expression | ISO | RGD:3932 | 6480464 | pirinixic acid results in increased expression of UCP2 mRNA | CTD | PMID:16782780 PMID:19162173 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of UCP2 mRNA | CTD | PMID:20813756 more ... |
| pirinixic acid | increases expression | ISO | RGD:3932 | 6480464 | pirinixic acid results in increased expression of UCP2 protein | CTD | PMID:19361538 more ... |
| pirinixic acid | multiple interactions | ISO | RGD:3932 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of UCP2 mRNA | CTD | PMID:11341955 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of UCP2 mRNA | CTD | PMID:20813756 more ... |
| pirinixic acid | increases expression | ISO | RGD:3932 | 6480464 | pirinixic acid results in increased expression of UCP2 protein | CTD | PMID:19361538 more ... |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of UCP2 mRNA | CTD | PMID:17426115 more ... |
| pirinixic acid | increases expression | ISO | RGD:3932 | 6480464 | pirinixic acid results in increased expression of UCP2 protein | CTD | PMID:18183618 more ... |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of UCP2 mRNA | CTD | PMID:16306350 more ... |
| pirinixic acid | affects response to substance | ISO | RGD:3932 | 6480464 | UCP2 protein affects the susceptibility to pirinixic acid | CTD | PMID:16782780 |
| pirinixic acid | increases expression | ISO | RGD:3932 | 6480464 | pirinixic acid results in increased expression of UCP2 protein | CTD | PMID:16782780 more ... |
| pirinixic acid | increases expression | ISO | RGD:3932 | 6480464 | pirinixic acid results in increased expression of UCP2 mRNA | CTD | PMID:19162173 PMID:16782780 |
| pirinixic acid | multiple interactions | ISO | RGD:3932 | 6480464 | L 663536 inhibits the reaction [pirinixic acid results in increased expression of UCP2 mRNA]; more ... | CTD | PMID:16782780 |
| pirinixic acid | multiple interactions | ISO | RGD:3932 | 6480464 | Glutathione inhibits the reaction [[pirinixic acid results in increased expression of UCP2 protein] which results in increased abundance of Hydrogen Peroxide]; more ... | CTD | PMID:19361538 |
| pirinixic acid | multiple interactions | ISO | RGD:3932 | 6480464 | Acetylcysteine inhibits the reaction [pirinixic acid results in increased expression of UCP2 protein]; more ... | CTD | PMID:18183618 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of UCP2 protein | CTD | PMID:16306367 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of UCP2 mRNA | CTD | PMID:16985257 more ... |
| pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid co-treated with rosiglitazone] results in increased expression of UCP2 mRNA | CTD | PMID:16306350 |
| pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid co-treated with PPARA] results in increased expression of UCP2 mRNA | CTD | PMID:20813756 |
| pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of UCP2 mRNA | CTD | PMID:19710929 |
| potassium cyanide | multiple interactions | ISO | RGD:3932 | 6480464 | dihydroxy-vitamin D3 inhibits the reaction [pirinixic acid promotes the reaction [Potassium Cyanide results in increased expression of UCP2 protein]]; more ... | CTD | PMID:18183618 |
| potassium cyanide | increases expression | ISO | RGD:3932 | 6480464 | Potassium Cyanide results in increased expression of UCP2 protein | CTD | PMID:18183618 |
| potassium cyanide | multiple interactions | ISO | RGD:3932 | 6480464 | [[pirinixic acid results in increased expression of UCP2 protein] which results in decreased expression of BCL2 protein] which results in increased susceptibility to Potassium Cyanide; more ... | CTD | PMID:19361538 |
| prostaglandin D2 | affects chemical synthesis | EXP | | 6480464 | UCP2 protein affects the chemical synthesis of Prostaglandin D2 | CTD | PMID:19846869 |
| quercetin | increases expression | ISO | RGD:69170 | 6480464 | Quercetin results in increased expression of UCP2 mRNA | CTD | PMID:21632981 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of UCP2 mRNA | CTD | PMID:19934007 PMID:22878646 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of UCP2 mRNA | CTD | PMID:22878646 |
| resveratrol | multiple interactions | EXP | | 6480464 | [resveratrol co-treated with Oxygen deficiency] results in increased expression of UCP2 protein | CTD | PMID:21113404 |
| resveratrol | multiple interactions | EXP | | 6480464 | PRKAA1 protein promotes the reaction [resveratrol results in increased expression of UCP2 mRNA]; more ... | CTD | PMID:19934007 |
| rosiglitazone | increases expression | ISO | RGD:69170 | 6480464 | rosiglitazone results in increased expression of UCP2 mRNA; more ... | CTD | PMID:17255338 |
| rosiglitazone | multiple interactions | EXP | | 6480464 | rosiglitazone inhibits the reaction [Oxygen deficiency results in decreased expression of UCP2 mRNA] | CTD | PMID:21113404 |
| rosiglitazone | increases expression | ISO | RGD:3932 | 6480464 | rosiglitazone results in increased expression of UCP2 mRNA | CTD | PMID:21172411 PMID:21515302 |
| rosiglitazone | increases expression | ISO | RGD:69170 | 6480464 | rosiglitazone results in increased expression of UCP2 mRNA | CTD | PMID:10548525 more ... |
| rosiglitazone | increases expression | ISO | RGD:69170 | 6480464 | rosiglitazone results in increased expression of UCP2 mRNA | CTD | PMID:17255338 more ... |
| rosiglitazone | increases expression | ISO | RGD:69170 | 6480464 | rosiglitazone results in increased expression of UCP2 mRNA | CTD | PMID:18155663 more ... |
| rosiglitazone | increases expression | ISO | RGD:69170 | 6480464 | rosiglitazone results in increased expression of UCP2 mRNA | CTD | PMID:15619071 more ... |
| rosiglitazone | affects expression | EXP | | 6480464 | rosiglitazone affects the expression of UCP2 mRNA | CTD | PMID:22013433 |
| rosiglitazone | multiple interactions | ISO | RGD:69170 | 6480464 | bexarotene promotes the reaction [rosiglitazone results in increased expression of UCP2 mRNA] | CTD | PMID:10548525 |
| rosiglitazone | increases expression | ISO | RGD:69170 | 6480464 | rosiglitazone results in increased expression of UCP2 mRNA | CTD | PMID:15619071 more ... |
| rosiglitazone | affects response to substance | ISO | RGD:3932 | 6480464 | UCP2 mRNA affects the susceptibility to rosiglitazone | CTD | PMID:20404217 |
| rosiglitazone | increases expression | EXP | | 6480464 | rosiglitazone results in increased expression of UCP2 mRNA | CTD | PMID:17245590 |
| rosiglitazone | multiple interactions | EXP | | 6480464 | rosiglitazone inhibits the reaction [Ethanol results in decreased expression of UCP2 mRNA] | CTD | PMID:20007851 |
| rosiglitazone | increases expression | ISO | RGD:3932 | 6480464 | rosiglitazone results in increased expression of UCP2 mRNA | CTD | PMID:21172411 |
| rosiglitazone | multiple interactions | ISO | RGD:3932 | 6480464 | rosiglitazone inhibits the reaction [Palmitates results in increased expression of UCP2 mRNA] | CTD | PMID:16620699 |
| rosiglitazone | increases expression | ISO | RGD:3932 | 6480464 | rosiglitazone results in increased expression of UCP2 protein | CTD | PMID:17052689 |
| rosiglitazone | multiple interactions | EXP | | 6480464 | [pirinixic acid co-treated with rosiglitazone] results in increased expression of UCP2 mRNA | CTD | PMID:16306350 |
| rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of UCP2 protein | CTD | PMID:18082129 |
| stavudine | decreases expression | ISO | RGD:69170 | 6480464 | Stavudine results in decreased expression of UCP2 mRNA | CTD | PMID:14518702 |
| succimer | multiple interactions | EXP | | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of UCP2 mRNA | CTD | PMID:21641980 |
| superoxide | multiple interactions | ISO | RGD:3932 | 6480464 | [[benzo(a)pyrene-1,6-quinone results in increased abundance of Superoxides] co-treated with [benzo(a)pyrene-1,6-quinone results in decreased abundance of Hydrogen Peroxide]] results in increased expression of UCP2 mRNA | CTD | PMID:10860543 |
| tamoxifen | affects expression | EXP | | 6480464 | Tamoxifen affects the expression of UCP2 mRNA | CTD | PMID:17555576 |
| telmisartan | multiple interactions | EXP | | 6480464 | PPARD promotes the reaction [telmisartan results in increased expression of UCP2 protein] | CTD | PMID:20176998 |
| telmisartan | increases expression | EXP | | 6480464 | telmisartan results in increased expression of UCP2 protein | CTD | PMID:20176998 |
| tetrachloromethane | increases expression | ISO | RGD:3932 | 6480464 | Carbon Tetrachloride results in increased expression of UCP2 mRNA | CTD | PMID:18420326 PMID:18314881 |
| tetrachloromethane | increases expression | ISO | RGD:3932 | 6480464 | Carbon Tetrachloride results in increased expression of UCP2 protein | CTD | PMID:18314881 |
| tetrachloromethane | multiple interactions | ISO | RGD:3932 | 6480464 | gadolinium chloride inhibits the reaction [Carbon Tetrachloride results in increased expression of UCP2 mRNA]; more ... | CTD | PMID:18314881 |
| tetrachloromethane | increases expression | ISO | RGD:3932 | 6480464 | Carbon Tetrachloride results in increased expression of UCP2 mRNA | CTD | PMID:18314881 PMID:18420326 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of UCP2 mRNA | CTD | PMID:19934007 PMID:22878646 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of UCP2 mRNA | CTD | PMID:22878646 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | [resveratrol co-treated with Oxygen deficiency] results in increased expression of UCP2 protein | CTD | PMID:21113404 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | PRKAA1 protein promotes the reaction [resveratrol results in increased expression of UCP2 mRNA]; more ... | CTD | PMID:19934007 |
| trichostatin A | increases expression | ISO | RGD:3932 | 6480464 | trichostatin A results in increased expression of UCP2 mRNA | CTD | PMID:12588052 |
| troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of UCP2 mRNA | CTD | PMID:12953171 |
| troglitazone | increases expression | ISO | RGD:3932 | 6480464 | troglitazone results in increased expression of UCP2 mRNA | CTD | PMID:21515302 PMID:9268716 |
| troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of UCP2 mRNA | CTD | PMID:12953171 PMID:11089532 |
| troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of UCP2 mRNA | CTD | PMID:11056218 |
| troglitazone | increases expression | ISO | RGD:3932 | 6480464 | troglitazone results in increased expression of UCP2 mRNA | CTD | PMID:9268716 |
| troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of UCP2 mRNA | CTD | PMID:11089532 PMID:12953171 |
| troglitazone | multiple interactions | EXP | | 6480464 | [troglitazone results in increased activity of PPARG protein] which results in increased expression of UCP2 mRNA | CTD | PMID:11089532 |
| vancomycin | decreases expression | EXP | | 6480464 | Vancomycin results in decreased expression of UCP2 mRNA | CTD | PMID:18930951 |